← All organizations

Cerecor Inc

For profitWebsite ↗

Also known as: Cerecor Inc | CERECOR INC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

First marketed drug

Last known activity

Sep 3, 2021

Timeline

2010s

Jun 1, 2011
Cerecor Inc— Founded
Mar 26, 2013
rabeprazole— NDA Secondary Org
Nov 17, 2017
Zylera Pharmaceuticals— Acquired
Sep 25, 2018
Ichorion Therapeutics— Acquired
Dec 5, 2019
Aevi Genomic Medicine— Acquired

Drugs by trial phase (12 distinct, 23 trials)

Phase 3 (0 own, 1 via acquisition)

fasoracetam

Phase 2 (3 own, 5 via acquisition)

Phase 1 (1 own, 2 via acquisition)

Indications

Studied for

Marketed drugs (1)

rabeprazole

Subsidiaries (3 direct, 3 total across the full acquisition tree)

Recent trials (13)

NCT04994002Lead sponsorPhase 1Sep 3, 2021
NCT04752371Lead sponsorPhase 1Mar 25, 2021
NCT02800928CollaboratorPhase 2Jun 1, 2016
NCT02641028Lead sponsorPhase 2Dec 1, 2015
NCT02641028Study directorPhase 2Dec 1, 2015
NCT02459236Study directorPhase 2Jun 1, 2015
NCT02459236Lead sponsorPhase 2Jun 1, 2015
NCT01941043Study directorPhase 2Nov 1, 2013
NCT01941043Lead sponsorPhase 2Nov 1, 2013
NCT01703923Study chairPhase 2Nov 1, 2012
NCT01703923Lead sponsorPhase 2Nov 1, 2012
NCT01597349Lead sponsorPhase 2May 1, 2012
NCT01579526Lead sponsorPhase 1Apr 1, 2012

Details

Founded: Baltimore, MD, US Jun 1, 2011
Last known activity: Sep 3, 2021